Literature DB >> 11507091

Recognition of alpha 2-macroglobulin by the low density lipoprotein receptor-related protein requires the cooperation of two ligand binding cluster regions.

I Mikhailenko1, F D Battey, M Migliorini, J F Ruiz, K Argraves, M Moayeri, D K Strickland.   

Abstract

The low density lipoprotein receptor-related protein (LRP) is a scavenger receptor that binds several ligands including the activated form of the pan-proteinase inhibitor alpha(2)-macroglobulin (alpha(2)M*) and amyloid precursor protein, two ligands genetically linked to Alzheimer's disease. To delineate the contribution of LRP to this disease, it will be necessary to identify the sites on this receptor which are responsible for recognizing these and other ligands to assist in the development of specific inhibitors. Structurally, LRP contains four clusters of cysteine-rich repeats, yet studies thus far suggest that only two of these clusters (clusters II and IV) bind ligands. Identifying binding sites within LRP for certain ligands, such as alpha(2)M*, has proven to be difficult. To accomplish this, we mapped the binding site on LRP for two inhibitors of alpha(2)M* uptake, monoclonal antibody 8G1 and an amino-terminal fragment of receptor-associated protein (RAP D1D2). Surprisingly, the inhibitors recognized different clusters of ligand binding repeats: 8G1 bound to repeats within cluster I, whereas the RAP fragment bound to repeats within cluster II. A recombinant LRP mini-receptor containing the repeats from cluster I along with three ligand binding repeats from cluster II was effective in mediating the internalization of (125)I-labeled alpha(2)M*. Together, these studies indicate that ligand binding repeats from both cluster I and II cooperate to generate a high affinity binding site for alpha(2)M*, and they suggest a strategy for developing specific inhibitors to block alpha(2)M* binding to LRP by identifying molecules capable of binding repeats in cluster I.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11507091     DOI: 10.1074/jbc.M104382200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Interaction of the apolipoprotein E receptors low density lipoprotein receptor-related protein and sorLA/LR11.

Authors:  R Spoelgen; K W Adams; M Koker; A V Thomas; O M Andersen; P J Hallett; K K Bercury; D F Joyner; M Deng; W H Stoothoff; D K Strickland; T E Willnow; B T Hyman
Journal:  Neuroscience       Date:  2008-11-08       Impact factor: 3.590

2.  Neuronal low-density lipoprotein receptor-related protein 1 binds and endocytoses prion fibrils via receptor cluster 4.

Authors:  Angela Jen; Celia J Parkyn; Roy C Mootoosamy; Melanie J Ford; Alice Warley; Qiang Liu; Guojun Bu; Ilia V Baskakov; Søren Moestrup; Lindsay McGuinness; Nigel Emptage; Roger J Morris
Journal:  J Cell Sci       Date:  2010-01-15       Impact factor: 5.285

3.  Serpin-Enzyme Receptors LDL Receptor-Related Protein 1.

Authors:  Dudley K Strickland; Selen Catania Muratoglu; Toni M Antalis
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

4.  Molecular basis for the interaction of low density lipoprotein receptor-related protein 1 (LRP1) with integrin alphaMbeta2: identification of binding sites within alphaMbeta2 for LRP1.

Authors:  Sripriya Ranganathan; Chunzhang Cao; Jason Catania; Molly Migliorini; Li Zhang; Dudley K Strickland
Journal:  J Biol Chem       Date:  2011-06-15       Impact factor: 5.157

5.  High Affinity Binding of the Receptor-associated Protein D1D2 Domains with the Low Density Lipoprotein Receptor-related Protein (LRP1) Involves Bivalent Complex Formation: CRITICAL ROLES OF LYSINES 60 AND 191.

Authors:  Joni M Prasad; Patricia A Young; Dudley K Strickland
Journal:  J Biol Chem       Date:  2016-07-11       Impact factor: 5.157

Review 6.  Endothelial LRP1 - A Potential Target for the Treatment of Alzheimer's Disease : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.

Authors:  Steffen E Storck; Claus U Pietrzik
Journal:  Pharm Res       Date:  2017-09-25       Impact factor: 4.200

7.  LRAD3, a novel low-density lipoprotein receptor family member that modulates amyloid precursor protein trafficking.

Authors:  Sripriya Ranganathan; Nathaniel C Noyes; Mary Migliorini; Jeffrey A Winkles; Frances D Battey; Bradley T Hyman; Elizabeth Smith; Manuel Yepes; Irina Mikhailenko; Dudley K Strickland
Journal:  J Neurosci       Date:  2011-07-27       Impact factor: 6.167

8.  K Domain CR9 of Low Density Lipoprotein (LDL) Receptor-related Protein 1 (LRP1) Is Critical for Aggregated LDL-induced Foam Cell Formation from Human Vascular Smooth Muscle Cells.

Authors:  Paula Costales; Pablo Fuentes-Prior; Jose Castellano; Elena Revuelta-Lopez; Maria Ángeles Corral-Rodríguez; Laura Nasarre; Lina Badimon; Vicenta Llorente-Cortes
Journal:  J Biol Chem       Date:  2015-04-27       Impact factor: 5.157

9.  The mosaic receptor sorLA/LR11 binds components of the plasminogen-activating system and platelet-derived growth factor-BB similarly to LRP1 (low-density lipoprotein receptor-related protein), but mediates slow internalization of bound ligand.

Authors:  Jørgen Gliemann; Guido Hermey; Anders Nykjaer; Claus M Petersen; Christian Jacobsen; Peter A Andreasen
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

10.  Regulation of tumor necrosis factor receptor-1 and the IKK-NF-kappaB pathway by LDL receptor-related protein explains the antiinflammatory activity of this receptor.

Authors:  Alban Gaultier; Sanja Arandjelovic; Sherry Niessen; Cheryl D Overton; MacRae F Linton; Sergio Fazio; W Marie Campana; Benjamin F Cravatt; Steven L Gonias
Journal:  Blood       Date:  2008-03-27       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.